Study design, patient eligibility and treatment This was a phase 1, first-in-human, open-label, nonrandomized, dose-escalation ...
Gatto, M., Zen, M., Cruciani, C., Iaccarino, L. & Doria, A. Navigating the landscape of ...
Patient enrollment, demographics, and clinical characteristics A graphical representation of the study schematic and anticipated ...
Study design The NATRON study, a double-blind, 24-week, phase 3, randomized, placebo-controlled trial with an ...
Patients Complete eligibility criteria are shown in Supplementary Table 6. Sex was recorded as a ...
Competing interests M.S.v.d.H. has received institutional funding from Bristol Myers Squibb to finance the INDIBLADE ...
Study design and treatments Approval Human subject work was performed in accordance with an approved ...
Study design For this randomized, open-label, single-centre, phase 2 trial, patients were enrolled at the ...
Bartholomeeusen, K. et al. Chikungunya fever. Nat. Rev. Dis. Primers 9, 17 (2023). Article PubMed ...
Trial participants Our study population comprised individuals aged 18 years or older with a diagnosis of ...